Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience. [electronic resource]
- Lupus Feb 2020
- 118-125 p. digital
Publication Type: Journal Article
1477-0962
10.1177/0961203319896018 doi
Adult Antineoplastic Agents--therapeutic use Bortezomib--adverse effects Cyclophosphamide--therapeutic use Drug Therapy, Combination Female Glucocorticoids--therapeutic use Humans Immunosuppressive Agents--therapeutic use Lupus Nephritis--drug therapy Proteinuria--drug therapy Remission Induction Retrospective Studies Rituximab--therapeutic use Young Adult